Belong.Life, a New York, NY-based world’s largest social network and navigator app for cancer patients, caregivers, and healthcare professionals, as per recent reports, has just closed a Series B funding round, raising $14 million in investment funding. The funding round was led by IQVIA, a Danbury, CT and Durham, NC-based life science analytics firm, and was participated by the Group Ventures and other existing investors.
The Belong app that caters to a global community of over 200k users, offers access to a proprietary big data platform and machine learning technology that allows users to seamlessly connect, receive, and share clinical information, anonymously. Employing the Belong Patient Engagement Platform provides healthcare organizations with an end-to-end engagement solution that offers personalized and configurable patient engagement tools, navigation, and management services.
With this recent funding, Belong plans to advance its new Patient Engagement Platform (PEP), which provides the necessary tools to hospitals, pharma, payers and patient advocacy groups to improve patient engagement, across a wide range of diseases.
“We are honored by the support and trust of IQVIA and our investors,” states Eliran Malki, co-founder & CEO of Belong.Life. “We at Belong are focused on building the most robust, hyper-personalized and configurable patient engagement and research platform. Starting with Belong – beating cancer together, we quickly grew to become the world’s largest social network and patient navigator app for cancer, collaborating with leading and disruptive researchers and publications in the market. Now, in addition to increasing our global cancer reach, Belong will bring its capabilities and expertise to additional diseases and stakeholders, to achieve the vision we established at the very beginning.”